Publication

Publication

  1. Mathews JA, Ford J, Norton S, Kang D, Dellinger A, Gibb DR, Ford AQ, Massay H, Kepley CL, Scherle P, Keegan AD, Conrad DH. A potential new target for asthma therapy: A Disintegrin and Metalloprotease 10 (ADAM10) involvement in murine experimental asthma. Allergy 2011; doi: 10.1111/j.1398-9995.2011.02614.x
  2. Joel A. Mathews, David R. Gibb, Bing-Hung Chen, Peggy Scherle, Daniel H. Conrad , “CD23 sheddase A Disintegrin And Metalloproteinase 10 (ADAM10) is also required for CD23 sorting into B cell derived exosomes. JBC 285(48): 37531–37541.
  3. Abstract: Joel Mathews, Bing-Hung Chen, Nayanendu Saha and Daniel Conrad,  “The interplay of CD23 and ADAM10 and its role in IgE synthesis”, The Journal of Immunology, 2009, 182, 139.1
  4. David R Gibb; Sheinei J Saleem; Natalia S Chaimowitz; Joel A Mathews; Daniel H Conrad, Ph.D., “The emergence of ADAM10 as a regulator of lymphocyte development and autoimmunity”, Mol. Immunol. (2011), doi:10.1016/j.molimm.2010.12.005
  5. Jamie L. Sturgill, Joel Mathews, and Daniel H. Conrad, “Glutamate signaling through the Kainate Receptor Enhances Human Immunoglobulin Production”, Journal of Neuroimmunology, 2011 Apr;233(1-2):80-9